
Arzerra Injection

Save more with additional offers








General Information



Product introduction
Arzerra Injection is administered subcutaneously (under the skin). Administer the medicine as prescribed and do not skip any doses, as consistency helps maintain its effectiveness. To get the most benefit, follow up with your doctor regularly, stay up to date with vaccinations before starting treatment, and monitor for any signs of infection.
Common side effects of Arzerra Injection include injection-site reactions such as redness, swelling, or pain, as well as flu-like symptoms like fever, headache, chills, and fatigue, especially after the first doses. These symptoms usually improve with time. Some people may experience upper respiratory infections or urinary tract infections. Staying hydrated and practicing good hygiene can help reduce the risk. If side effects become severe or do not go away, consult your doctor for guidance.
Since Arzerra Injection lowers certain immune cells, it can increase the risk of infections, including serious ones like hepatitis B reactivation or upper respiratory infections. Before starting treatment, your doctor may check for infections and ensure your vaccinations are up-to-date. Avoid live vaccines while on treatment with Arzerra Injection, as they may not be safe. If you develop signs of infection, such as a persistent fever, sore throat, or unusual tiredness, seek medical advice promptly. People with a weakened immune system or a history of hepatitis B should discuss risks with their doctor before starting Arzerra Injection.
Pregnant or breastfeeding women should consult their doctor before using Arzerra Injection, as it may harm the baby. Both men and women should use effective contraception during treatment to prevent pregnancy. Arzerra Injection is a strong medication, so always follow your doctor's advice and report any concerns promptly to ensure the best results while minimizing risks.
Uses of Arzerra Injection
- Treatment of Relapsing forms of multiple sclerosis (MS)
Benefits of Arzerra Injection
In individuals with relapsing forms of multiple sclerosis (MS), Arzerra Injection helps prevent relapses and slows the disability progression. It also helps reduce inflammation, decrease the frequency of flare-ups, minimize nerve damage, and improve long-term outcomes. When used as prescribed, Arzerra Injection helps patients maintain their independence, stay active, and improve their overall quality of life.
Side effects of Arzerra Injection
- Headache
- Fever
- Muscle pain
- Chills
- Tiredness
- Injection site reactions (pain, swelling, redness)
- Upper respiratory tract infection
- Urinary tract infection
How to use Arzerra Injection
How Arzerra Injection works
Quick tips
- Administer Arzerra Injection as prescribed to maintain effectiveness. Set reminders if needed.
- Report any signs of infection, such as fever, cough, or sore throat, to your doctor.
- Get necessary vaccines at least 4 weeks before starting treatment, and avoid live vaccines during treatment.
- Use birth control during treatment and for at least 6 months after stopping.
- Drink plenty of water and rest to ease flu-like side effects.
- Follow up regularly with your doctor to monitor progress and manage side effects early.
Safety advice

Alcohol

Pregnancy

Breast feeding

Driving

Kidney

Liver
Interaction with drugs
Herpes Zoster / Shingles Vaccine (Recombinant, Adjuvanted) (Injection Route)
Cholera Vaccine (Inactivated) (Oral Route)
Purified Vi Polysaccharide Typhoid Vaccine (Injection Route)
Fact Box
Chemical Class
Habit Forming
Therapeutic Class
Action Class
References
- Chabner BA, Barnes J, Neal J, et al. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1747-48.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1011.
- Ofatumumab [Prescribing Information]. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2024. [Accessed 03 Apr. 2025] (online) Available from:
- Ofatumumab [Summary of Product Characteristics]. Dublin 4, Ireland: Novartis Europharm Limited; 2021. [Accessed 03 Apr. 2025] (online) Available from:
- Ofatumumab [Professional Information]. Johannesburg, South Africa: Novartis South Africa (Pty) Ltd.; 2023. [Accessed 03 Apr. 2025] (online) Available from:




User feedback
Want to know more
We provide you with authentic, trustworthy and relevant informationHave issue with the content
Disclaimer
Marketer details
Address: Dr. Annie Besant Road, Mumbai - 400 030
Vendor Details
Lab tests offered by us
- CBC (Complete Blood Count)
- FBS (Fasting Blood Sugar)
- Thyroid Profile Total (T3, T4 & TSH)
- HbA1c (Glycosylated Hemoglobin)
- PPBS (Postprandial Blood Sugar)
- Lipid Profile
- Vitamin D (25-Hydroxy)
- Urine R/M (Urine Routine & Microscopy)
- Coronavirus Covid -19 test- RT PCR
- LFT (Liver Function Test)
- KFT (Kidney Function Test)
- TSH (Thyroid Stimulating Hormone) Ultrasensitive
- ESR (Erythrocyte Sedimentation Rate)
- Uric Acid, Serum
- Vitamin B12
- CRP (C-Reactive Protein), Quantitative
- Urine C/S (Urine Culture and Sensitivity)
- Serum Electrolytes
- Serum Calcium
- Serum Creatinine
- Diabetes Screening (HbA1C & Fasting Sugar)
- KFT with Electrolytes (Kidney Function Test with Electrolytes)
- Cholesterol - Total
- Hb (Hemoglobin)
- Complete Hemogram (CBC & ESR)



